Falcon Real World Evidence Registry

Part of paid clinical trials in Evanston, Illinois.

Sponsor
Exact Sciences Corporation
Study ID
NCT06589310
Status
Recruiting
Apply to this trial

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Exact Sciences Multicancer Early Detection (MCED) Test — DEVICE
    Exact Sciences MCED test, is a qualitative in vitro diagnostic (IVD) for the detection of alterations in circulating tumor DNA and tumor-associated protein levels, which are commonly associated with cancer. It is performed on plasma derived from peripheral blood specimens.

Study Details

This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.

Key Dates

Start date
Aug 1, 2024
Status verified
May 2026
Primary completion
Aug 31, 2030
Completion
Jan 31, 2031

Study Design

Enrollment
25,000 participants (estimated)

Arms

  • Arm: Multicancer Early Detection (MCED) cohort

Primary Outcome Measure

Vital status [ Time Frame: Up to 5 years ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Endeavor HealthEvanstonIllinois60201
Peter Hulick, M.D.
[email protected]
Henry (Mark) Dunnenberger, PharmD
[email protected]
Peter Hulick, M.D. (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White HealthDallasTexas75246
Keisha Riser, MBA
[email protected]
Ronan Kelly, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Evanston, IL

By research site
Endeavor Health· Evanston, ILBaylor Scott & White Health· Dallas, TX

Related Studies